Sanofi has temporarily stopped recruiting new COVID-19 patients for two clinical trials on hydroxychloroquine and will no longer supply the anti-malaria drug to treat COVID-19 until concerns about safety are cleared up, it said on Friday.
The moves come after the World Health Organization paused its large trial of hydroxychloroquine, prompting several European governments to ban the use of the drug, also used in rheumatoid arthritis and lupus.
Sanofi has been conducting two randomised, controlled clinical trials of hydroxychloroquine for COVID-19.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
New York Times Celebrates Broadway Season Cut Short by COVID-19 With ‘Offstage: Opening Night’ (EXCLUSIVE)The New York Times will celebrate a Broadway season that was brought to an abrupt and painful end by the coronavirus pandemic. The Gray Lady will salute the Great White Way with “Offstage: Op…
続きを読む »
Queen Elizabeth II allows Boris Johnson to exercise at Buckingham Palace during COVID-19 recoveryBritish Prime Minister Boris Johnson has been making trips to the Buckingham Palace grounds for exercise while recovering from coronavirus after Queen Elizabeth II gave her blessing.
続きを読む »
Germany to lift Covid-19 travel warnings 'in two stages'Berlin prepares to remove global travel warnings starting first with 26 EU member states and then for other countries, Foreign Ministry officials tell TRT World.
続きを読む »
Wanted in Hollywood: COVID-19 consultants to help keep sets safeAlong with hair stylists, camera operators and the hundreds of others who make magic happen for TV and film, Hollywood is counting on a new supporting member for future productions: COVID-19 consultants.
続きを読む »
Brazil Counts Almost Twice As Many Daily Covid-19 Deaths As The U.S.Brazil has reported nearly twice as many new Covid-19 deaths as the U.S. in the previous 24 hours Tuesday—a menacing marker as the country emerges as the world’s new epicenter for the virus
続きを読む »